| ²é¿´: 128 | »Ø¸´: 0 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
glzeng°æÖ÷
|
[½»Á÷]
ÇóÖú£ºÉúÎï»îÐԲⶨ£¨10½ð±Ò£©½éÉÜÒ»ÏÂÄÄÀï¿ÉÒÔ×öÕâ¸öʵÑé
|
||
|
ÕâÊÇÔÚһƬרÀûÉÏ¿´µ½µÄ£¬ÎÒ°ÑËü·ÒëÁËһϣ¬ÆäʵÎÒ×Ô¼ºÒ²²»ÍêÈ«¿´µÃ¶®£¬ÎÒ²»ÊÇ×öÉúÎï·½Ãæ£¬ËùÒÔ°ÝÍÐһϸ÷룬¿´Äܲ»ÄܽéÉÜÒ»ÏÂÕâ¸öʵÑéÔÚÄÄÀï¿ÉÒÔ×ö£¡ ʵÑéÄ¿µÄ£º ²â¶¨GA RSÏà¶Ô GA DSµÄÏà¶ÔÉúÎï»îÐÔ ÊµÑé·½°¸£º ÃâÒß ÖÆ±¸GA RSÈÜÒº ׼ȷ³ÆÈ¡15mg GA£¬ ÈܽâÔÚÎÞ¾úPBSÖÐÖÆ±¸5mg/mlµÄÈÜÒº ÖÆ±¸GA RSÈé×´Òº µÈÌå»ýGA RSÈÜÒº(5mg/ml)ºÍCFA»ìºÏ£¬»ìºÏÎï×ªÒÆÖÁÎÞ¾ú²£Á§×¢ÉäÆ÷£¬×¢ÉäÆ÷ͨ¹ýLuer bridgeÓëÁíÍâÒ»Ö»²£Á§×¢ÉäÆ÷ÏàÁ¬¡£Í¨¹ýÔÚÁ½Ö»×¢ÉäÆ÷Ö®¼äµÄÏà»¥×ªÒÆ¶øÊ¹Æä³ä·ÖÈ黯¡£Îȶ¨Èé×´ÒºµÄ¶¨ÒåÊÇÔÚË®ÃæÉÏÈé×´Òº²»·ÖÉ¢¡£ ×¢É䣺 ½«GA RSÈé×´Òº×ªÒÆÖÁÒȵºËØ×¢ÉäÆ÷£¬½«100µL GA RSÈé״ҺעÉ䵽С°×ÊóµÄËÄÖ»½ÅÕÆ(footpads)ÉÏ(ÿֻԼ25µL), ÃâÒßµÄС°×ÊóÓÃÓÚÌåÍâʵÑ飨9-11Ì죩 ÖÆ±¸³õ¼¶ÅàÑøµÄLNϸ°û ³õ¼¶ÅàÑøµÄLNϸ°ûµÄÈ¡×ÔÃâÒß9-11ÌìµÄС°×Êó¡£ÊÖÊõ֮ǰÔÚ¾»»¯ÕÖ/¹ñÖн«×ÏÍâµÆ´ò¿ª20min£¬ÊÖÊõ¿ªÊ¼Ê±¹Ø±Õ¡£ÔÚ½«ÊÔ¼Á·ÅÈë¾»»¯ÕÖ֮ǰÓÃ70£¥ÒÒ´¼ÈÜÒºÇå½à¹¤×÷Ì¨Ãæ¡£ ÖÆ±¸Enriched DCCM1 medium£¬Enriched DCCM1 mediumºÍRPMI mediumÔÚʹÓÃǰԤÈÈÖÁ37¡æ£¬½«Ð¡°×ÊóɱËÀºó£¨Å¤¶Ï²±×Ó£©¹Ì¶¨ÔÚÖ§³Åƽ̨ÉÏ£¬±³²¿×ŵء£¸¹²¿ÓÃ70£¥ÒÒ´¼Ïû¶¾ºóÇпªÒ»¸öÖеȴóСµÄ¿Ú×Ó£¬£¨Çпڳ¤¶Èͨ³£Îª2 cm£©£¬½«LN×ªÒÆÖÁº¬ÓÐÔ¼5mlÎÞ¾úRPMI mediumµÄÎÞ¾úÅàÑøÃóÖУ¬LNϸ°ûÐü¸¡ÒºÓÃÎÞ¾ú×¢ÉäÆ÷´ÓÅàÑøÃó×ªÒÆÖÁ50ml ÎÞ¾úÊԹܡ£ ϸ°û¼ÆÊý£º ×°ÓÐϸ°ûÐü¸¡ÒºµÄÎÞ¾úÊÔ¹ÜÖмÓÈëRPMI mediumÖÁ40ml£¬LNϸ°ûÔÚÊÒÎÂÏÂÀëÐÄ·ÖÀ루200¡Ág£©10min£¬¹ÌÌåÖØÐ·ÖÉ¢ÔÚ40mlRPMIÖУ¬Two aliquots of 50µL were drawn each from the cells¡¯ suspension diluted 4-fold with 150µL of 0.1% Trypan blue£¨×¶³æÀ¶£© in a microtest well. The aliquots were mixed wel by pipetting gently up and down¡£ÓøDz£Æ¬¸²¸ÇѪÇò¼Æ£¬½«Á½¸öaliquotÓÃ50£200µLµÄÒÆÒº¹ÜÒÆÈëѪÇò¼ÆµÄÉÏÏÂÁ½¸öchamberÖУ¬»ìºÏÎϸ°ûÐü×ÇÒººÍ×¶³æÀ¶£©¿ÉÔÚchamberÖзÅÖÃÁ½·ÖÖÓ£¬²¢¿ÉÒÔ¸²¸ÇÕû¸öchamberµÄ±íÃæ£¬Èç¹ûchamberÖгöÏÖÆøÅÝ»òÕß¹ýÁ¿ÔòÐ轫ѪÇò¼ÆÍêÈ«ÇåÀí¸É¾»²¢¸ÉÔïºóÖØÐÂÉÏÑù¡£»îµÄϸ°û²»ÄÜÓë×¶³æÀ¶½áºÏ¶ø³ÊÏÖÎÞɫ״̬£¬ËÀϸ°ûÔòÓë×¶³æÀ¶½áºÏ¶øÏÔÀ¶É«¡£¼ÆËãϸ°û¼ÆÊý°åÖÐÑë·½¸ñÖеĻîϸ°ûÊýÄ¿£¬·½¸ñÖбßÔµµÄϸ°ûÖ»Óе±Ï¸°ûÈ«²¿ÔÚ·½¸ñÖвżÆÊý£¬Ï¸°ûÃܶÈͨ¹ýÏÂÃæµÄ¹«Ê½¼ÆË㣺 Average number viable cells(both chambles) ¡Á4¡Á104£½cells/ml ½«LNϸ°ûÔÚÊÒÎÂÏÂÀëÐÄ·ÖÀ루200¡Ág£©10min£¬¹ÌÌå·ÖÉ¢ÔÚenriched DCCM1ÖÐ,ÐγÉÃܶÈΪ1¡Á107 cells/mlµÄÈÜÒº¡£ ÌåÍâÉúÎï²â¶¨ ÌåÍâÉúÎï²â¶¨ÔÚFlat-bottomed ϸ°ûÅàÑø²âÊÔ°åÉϽøÐУ¬×îÖÕÌå»ýΪ1ml ÖÆ±¸GA RSУÕýÇúÏß Ò»¸öaliquotµÄ1 mg/ml GARSÓÃenriched DCCM1 mediumÏ¡ÊÍÖÁ100 µg/ml(10±¶)£¬ÓÃ0.2 µ ´×ËáÏËÎ¬ËØ¹ýÂË£¬ÖƱ¸6¸öŨ¶ÈΪ2-50 µg/mlµÄenriched DCCM1 mediumºÍGA RSÈÜÒº¡£ ÖÆ±¸Ï¡Å¨¶ÈGA DSÈÜÒº ׼ȷ³ÆÈ¡10-20 mg GA DSÈܽâÔÚddH2OÖÐÖÆ±¸1.2 mg/mlµÄÈÜÒº£¬¹âѧÃܶȣ¨OD£©ÔÚ275 nm´¦²â¶¨¡£ODÖµµ÷ÖÁ1.03£¬ÖƱ¸1 mg/mlÈÜÒº£¬È»ºóÓÃDCCM1Åä³É100 µg/mlÈÜÒº£¬ÓÃ0.2µ´×ËáÏËÎ¬ËØ¹ýÂË£¬¸ÃÈÜҺϡÊÍÖÁ10ºÍ20 µg/ml£¬ÈçÉÏ±í¡£ ²â¶¨·´Ó¦£º ÏÂÃæÕâЩÈÜÒº¼ÓÈëµ½24¸ñϸ°ûÅàÑø²âÊÔ°å GA RS 0.5 ml LNϸ°û£¨×îºóÃܶÈÈ磺5¡Á106 cells/well£©£¬Ã¿¸öGA RSÏ¡ÊÍÒº0.5 ml£¬ÔÚ¸ñÖеÄ×îºóŨ¶ÈΪ£º25£¬15£¬10£¬5£¬2.5£¬1 µg/ml¡£ GA DSÑùÆ· 0.5 ml LNϸ°û£¨×îºóÃܶÈÈ磺5¡Á106 cells/well£©£¬Ã¿¸öGA DSÏ¡ÊÍÒº0.5 ml£¬ÔÚ¸ñÖеÄ×îºóŨ¶ÈΪ£º5£¬10 µg/ml¡£ ÿ¸ö²âÊÔ¶¼°üº¬ÈçÏ¿ØÖÆ£º 1£© ¸º¿ØÖÆ£ ÓÿØÖÆëÄÅàÑøLNϸ°û 0.5 ml LNϸ°û£¨×îºóÃܶȣº5¡Á106 cells/well£© 0.5 ml MBPëÄÈÜÒº£¨20 µg/ml£©ÓÃDCCM1Ï¡ÊÍ£¨×îºóŨ¶ÈΪ10 µg/ml£© 2£©Õý¿ØÖÆ£ÓÃCon A£¨·ÇÌØÒìÐÔTϸ°û´Ì¼¤¼Á£©´Ì¼¤LNϸ°û 0.5 ml LNϸ°û£¨×îºóÃܶȣº5¡Á106 cells/well£© 0.5 ml Con A£¨5 µg/ml£©ÓÃDCCM1Ï¡ÊÍ£¨×îºóŨ¶ÈΪ2.5 µg/ml£© ϸ°ûÃܶÈËæ×ÅËûÃǶÔGAµÄ·´Ó¦¶ø·¢Éú±ä»¯¡£ÅàÑøÌõ¼þΪ37 ¡æ£¬Êª¶È5£¥CO2±£ÎÂÏäÖÐ18-21 h£¬²âÊÔ°åÔÚÊÒÎÂÏÂÀëÐÄ10 min£¨200¡Ág£©£¬ÉÏÇåÒº×ªÒÆÖÁµÍιÜÖУ¬ÔÚ£20¡æÏ¿ɱ£´æÒ»ÐÇÆÚ¡£ øÁªÃâÒßÎü¸½²â¶¨£¨ELISA£©°×½éËØ-2¼ì²â ËùÓÐÑùÆ·²â¶¨´ÎÊýΪÈý´Î£¬Ã¿¸öplate¶¼°üº¬ÒÔÏ£º 1£© °×½éËØ-2±ê×¼ÇúÏߣ°üº¬ÖÁÉÙ6¸ö·ÇÁãŨ¶È°×½éËØ-2 2£© ¿Õ°×£«µÚÒ»¸ö¿¹Ì壬ûÓа׽éËØ-2 standard£¬£«µÚ¶þ¸ö¿¹Ì壨Áãµã£© 3£© GA RSÅàÑøÃ½½é,²âÊÔÑùÆ·ÓÃDCCM1Ï¡ÊÍ£¬·½·¨ÈçÏ a) 1, 2.5 µg/mlGA RS ÑùÆ·ÒÔ¼°·´¿ØÖÆÑùÆ·Ï¡ÊÍ2±¶ b) 5-25 µg/ml GA RS ÑùÆ·ºÍ²âÊÔÑùÆ·Ï¡ÊÍ5-10±¶ c) Õý¿ØÖÆÑùÆ·(Con A)Ï¡ÊÍ15-20±¶ ²â¶¨°×½éËØ-2ˮƽµÄELISA·½°¸°´ÕÕÖÆÔìÉÌÌṩµÄ·½·¨½øÐУ¬Èç¹û´ý²âÑùÆ·µÄODÖµ³¬¹ý»òµÍÓÚPlate readerµÄ¼«ÏÞÖµ£¬ÔòÑùÆ·ÐèÖØÐÂÅäÖúó½øÐзÖÎö¡£ ¼ÆËãºÍ¿É½ÓÊܱê×¼ øÁªÃâÒßÎü¸½²â¶¨ ʵÀý2 ʵÑé2A£ºGA RS ÌØÒìÐÔTϸ°û·ÖÃÚµÄϸ°ûÒò×Ó ÓÃ250 µg/mlGA RS/CFA¶Ô´ÆÐÔF1ÀÏÊóÃâÒß9-11Ì죬½«LNϸ°ûÌáÈ¡³öÀ´ºóÓò»Í¬Å¨¶ÈGA RSÅàÑø18-24 h£¬ÅàÑøÌõ¼þΪΪ37 ¡æ£¬Êª¶È5£¥CO2±£ÎÂÏäÖС£½ÓÏÂÀ´È¡ÆäÀëÐÄÉÏÇåÒºÓÃÓÚϸ°ûÒò×Ӳⶨ¡£ ÓöÔϸ°ûÒò×ÓºÍÁ´Ã¹¿¹ÉúËØµ°°×£ËØÀ±¸ù¹ýÑõ»¯Îïø¾ßÓÐÌØÒìÐÔµÄÉúÎïËØ»¯¿¹Ìå½øÐÐøÁªÃâÒßÎü¸½²â¶¨¡£Ã¿¸öplate°üÀ¨¿Õ°×¿ØÖÆ£¨µÚÒ»¸öºÍµÚ¶þ¸ö¿¹Ìå²»º¬Ï¸°ûÒò×Ó±ê׼Ʒ£©£¬ÖÊÁ¿¿ØÖÆ£¨QC£©ÑùÆ·£¨Èý¸öŨ¶ÈÔÚ²âÊÔÏßÐÔ·¶Î§ÄÚµÄϸ°ûÒò×Ó±ê׼Ʒ£©¡£Ã¿¸öÌåÍâ²âÊÔ°üº¬Ò»¸öÕý¿ØÖÆ£¨Con A£¬·ÇÌØÒìÐÔTϸ°û´Ì¼¤¼Á£©ºÍÒ»¸ö¸º¿ØÖÆ£¨²»º¬GA»òÆäËû¿¹Ô£©£¬ËùÓÐϸ°ûÒò×ӵIJâÊÔ¶¼ÔÚÅàÑø18-24 hÒÔºó¡£TGF-¦Â,IL-10ºÍIL-4ˮƽÔÚÅàÑø72СʱºóÔٴβⶨ¡£½á¹ûÈçÏ£º £¨-£©Ð¡ÓÚ¼ì²âÏÞ£¬£¨+£©´ïµ½Ô¼400 pg/ml£¬(++)´óÓÚ400 pg/ml¡£±íÖÐÊý¾Ý±íÃ÷£¬ÔÚGA RSµÄ´Ì¼¤Ï£¬LNϸ°û·ÖÃÚ³öIL-2£¬INF-¦Ã£¬IL-10ºÍIL-6£¬µ«ÊÇTNF-¦Á£¬IL-4£¬IL-13£¬TGF-¦ÂÔòδ¼ì²âµ½¡£±íÃ÷GA RS ÌØÒìÐÔTϸ°û·ÖÃÚµÄϸ°ûÒò×ÓÊÇTH0Ð͵ġ£ ÓÉÓÚ·ÖÃÚµÄIL-2ÓëGA RS ¾ßÓкܺõÄÖØÏÖÐÔ¼°ÏßÐÔ¹ØÏµ£¬ËùÒÔIL-2ÊǺâÁ¿Tϸ°û¼¤»îµÄ×î¼Ñϸ°ûÒò×Ó¡£ ʵÑé2B£ºÓÅ»¯ÃâÒß¹ý³Ì ΪÁËÓÅ»¯ÃâÒß·½°¸£¬Éè¼ÆÈçÏÂʵÑé¡£µÚÒ»¸öʵÑé²âÊÔGA RS£¨ÃâÒß¿¹Ô£©¼ÁÁ¿¶ÔÁÜ°ÍºÍÆ¢ÔàÖеÄTϸ°û·´Ó¦µÄÓ°Ïì¡£½á¹û±íÃ÷ÁܰÍÖÐTϸ°û·ÖÃÚµÄIL-2±ÈÆ¢ÔàÖзÖÃڵĶ࣬Òò´ËÑ¡Ôñ³õ¼¶ÅàÑøµÄLNϸ°ûÓÃÓÚ²âÊÔ¡£ÁíÍ⣬ÔÚÅàÑø¹ý³ÌÖУ¬GA RSµÄ¼ÁÁ¿¶ÔTϸ°û·´Ó¦Ã»ÓÐÓ°Ïì¡£ÔÚGA RS ¼ÁÁ¿²»Í¬µÄÇé¿öÏ£¬LNºÍÆ¢Ôàϸ°û¶¼ÄÜ·ÖÃÚµÈÁ¿µÄIL-2£¬Õâ±íÃ÷ÃâÒß¹ý³ÌÊǽ¡¿µµÄ£¬¼´Ê¹GA RS¼ÁÁ¿²î±ðºÜ´óÒ²²»Ó°ÏìÃâÒß½á¹û¡£ ½øÒ»²½ÓÅ»¯ÃâÒß·½°¸£¬ ʵÑé±íÃ÷ÿֻС°×Êó×¢Éä250 µg GA RS+CFA±ÈÿֻעÉä10 mgGA£«ICFA(½ÏÈõµÄ¸¨ÁÏ)ÒªºÃµÃ¶à¡£250 µg/Ö»ÄܺÜÓÐЧµÄBlock EAE(ÖÁÉÙ80£¥) ÌØÒìÐÔTϸ°ûͨ³£ÔÚÃâÒß10Ìì×óÓҲŲúÉú£¬Òò´ËÃâÒßʱ¼äΪ9-11Ìì¡£ ʵÑé2C£ºÓÅ»¯ÌåÍâʵÑéÌõ¼þ 1¡¢ ÅàÑøÃ½½é ʵÑéÖÐÓõ½4¸öÅàÑøÃ½½é£º1£©RPMI+1%NMS£¬2) RPMI+1%FBS£¬3£©Biotarget£¬4£©DCCM1(²»º¬Serum ý½é)£¬ÆäÖÐ×îÓŵÄΪµÚËĸö¡£ 2¡¢ IL£2µÄ·ÖÃÚ¶¯Á¦Ñ§ ·ÖÃÚ¶¯Á¦Ñ§±íÃ÷ÅàÑøÊ±¼ä×î¼ÑΪ18-21h 3¡¢Ï¸°ûÒò×Ӳⶨ IL-2ͨ¹ýOptEIA(Pharmingen, Cat.#2614KI)-a ELISA kit specific for mouse IL-2£¬ÕâÖÖELISA kit·Ç³£ÁéÃô£¬½á¹û·Ç³£¾«È·£¬²¢ÇÒÖØÏÖÐԸߡ£ 4¡¢²âÊÔÑùÆ·ÖеÄIL-2ÔÚ£20¡æÏµÄÎȶ¨ÐÔ £20¡æ¿É±£´æÒ»ÐÇÆÚ¡£ 5¡¢GA RS ÈÜÒºÔÚ£20¡æÏµÄÎȶ¨ÐÔ £20¡æ¿É±£´æ5¸öÔ ʵÑé2D: ²â¶¨GA RS УÕýÇúÏßµÄÏßÐÔ·¶Î§ ʵÀý3£ºÊµÀýÒ»µÄ֤ʵ |
» ²ÂÄãϲ»¶
ÇóÖúÔÓÖ¾µÄEndnote²Î¿¼ÎÄÏ׸ñʽ
ÒѾÓÐ2È˻ظ´
2026»ù´¡Ò½Ñ§£¬ÐÄÔàµçÉúÀí£¬Ò©Àíѧ²©Ê¿×Ô¼ö
ÒѾÓÐ20È˻ظ´
Ô¤·ÀҽѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ185È˻ظ´
26¿¼Ñе÷¼Á£ü¿µ¸´Ñ§Ë¶
ÒѾÓÐ0È˻ظ´
Çóµ÷¼ÁÒ½¼¼£¨105800£©¡¢¿µÀí£¨100215£©
ÒѾÓÐ1È˻ظ´
100200ÁÙ´²Ñ§Ë¶×Ü·Ö329Çóµ÷¼ÁbÇøÑ§Ë¶
ÒѾÓÐ0È˻ظ´
¿µ¸´288
ÒѾÓÐ2È˻ظ´
һ־Ըҽѧ¼¼Êõ331
ÒѾÓÐ0È˻ظ´














»Ø¸´´ËÂ¥